Clostridium difficile MazF toxin exhibits selective, not global, mRNA cleavage

Journal of Bacteriology

Volumn 194, Issue 13, 2012, Pages 3464-3474

  Rothenbacher, Francesca P ^a   Suzuki, Motoo ^e   Hurley, Jennifer M ^a,f   Montville, Thomas J ^d   Kirn, Thomas J ^c   Ouyang, Ming ^b   Woychik, Nancy A ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b University of Louisville   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e KAGAWA UNIVERSITY   (Japan)

^f DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CELL MEMBRANE PROTEIN; CLOSTRIDIUM DIFFICILE TOXIN B; MESSENGER RNA; PROTEIN CWPV; PROTEIN MAZE; PROTEIN MAZF; TRANSCRIPTOME; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; CELL DEATH; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESCHERICHIA COLI; GROWTH INHIBITION; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA CLEAVAGE; RNA DEGRADATION; STATISTICAL ANALYSIS; TOXIN ANTITOXIN SYSTEM;

ANTITOXINS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BASE SEQUENCE; CLOSTRIDIUM DIFFICILE; ENDORIBONUCLEASES; HUMANS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SUBSTRATE SPECIFICITY;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; ESCHERICHIA COLI;

EID: 84864022357     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00217-12     Document Type: Article

References (56)

1. Aizenman E, Engelberg-Kulka H, Glaser G. 1996. An Escherichia coli chromosomal "addiction module" regulated by guanosine 3',5'-bispyrophosphate: a model for programmed bacterial cell death. Proc. Natl. Acad. Sci. U. S. A. 93:6059-6063.
2. Allen SP, Blaschek HP. 1990. Factors involved in the electroporationinduced transformation of Clostridium perfringens. FEMS Microbiol. Lett. 58:217-220.
3. Amitai S, Kolodkin-Gal I, Hananya-Meltabashi M, Sacher A, Engelberg-Kulka H. 2009. Escherichia coli MazF leads to the simultaneous selective synthesis of both "death proteins" and "survival proteins." PLoS Genet. 5:e1000390. doi:10.1371/journal.pgen.1000390.
4. Amitai S, Yassin Y, Engelberg-Kulka H. 2004. MazF-mediated cell death in Escherichia coli: a point of no return. J. Bacteriol. 186:8295- 8300.
5. Bignardi GE. 1998. Risk factors for Clostridium difficile infection. J. Hosp. Infect. 40:1-15.
6. Buts L, Lah J, Dao-Thi MH, Wyns L, Loris R. 2005. Toxin-antitoxin modules as bacterial metabolic stress managers. Trends Biochem. Sci. 30: 672-679.
7. De Jonge N, et al. 2009. Rejuvenation of CcdB-poisoned gyrase by an intrinsically disordered protein domain. Mol. Cell 35:154 -163.
8. Dodson AP, Borriello SP. 1996. Clostridium difficile infection of the gut. J. Clin. Pathol. 49:529 -532.
9. Emerson JE, et al. 2009. A novel genetic switch controls phase variable expression of CwpV, a Clostridium difficile cell wall protein. Mol. Microbiol. 74:541-556.
10. Emerson JE, Stabler RA, Wren BW, Fairweather NF. 2008. Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress. J. Med. Microbiol. 57:757-764.
11. Engelberg-Kulka H, Glaser G. 1999. Addiction modules and programmed cell death and antideath in bacterial cultures. Annu. Rev. Microbiol. 53:43-70.
12. Falla TJ, Chopra I. 1998. Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob. Agents Chemother. 42:3282-3284.
13. Fu Z, Donegan NP, Memmi G, Cheung AL. 2007. Characterization of MazFSa, an endoribonuclease from Staphylococcus aureus. J. Bacteriol. 189:8871- 8879.
14. Fuchs AR, Bonde GJ. 1957. The nutritional requirements of Clostridium perfringens. J. Gen. Microbiol. 16:317-329.
15. Garcia-Pino A, et al. 2010. Allostery and intrinsic disorder mediate transcription regulation by conditional cooperativity. Cell 142:101-111.
16. Gerdes K, Christensen SK, Lobner-Olesen A. 2005. Prokaryotic toxinantitoxin stress response loci. Nat. Rev. Microbiol. 3:371-382.
17. Guzman LM, Belin D, Carson MJ, Beckwith J. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 177:4121- 4130.
18. Harrison JJ, et al. 2009. The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob. Agents Chemother. 53:2253-2258.
19. Hartman AH, Liu H, Melville SB. 2011. Construction and characterization of a lactose-inducible promoter system for controlled gene expression in Clostridium perfringens. Appl. Environ. Microbiol. 77:471- 478.
20. Hazan R, Sat B, Engelberg-Kulka H. 2004. Escherichia coli mazEFmediated cell death is triggered by various stressful conditions. J. Bacteriol. 186:3663-3669.
21. Janvilisri T, Scaria J, Chang YF. 2010. Transcriptional profiling of Clostridium difficile and Caco-2 cells during infection. J. Infect. Dis. 202:282- 290.
22. Jiang W, Hou Y, Inouye M. 1997. CspA, the major cold-shock protein of Escherichia coli, is an RNA chaperone. J. Biol. Chem. 272:196 -202.
23. Jorgensen MG, Pandey DP, Jaskolska M, Gerdes K. 2009. HicA of Escherichia coli defines a novel family of translation-independent mRNA interferases in bacteria and archaea. J. Bacteriol. 191:1191-1199.
24. Kamada K, Hanaoka F, Burley SK. 2003. Crystal structure of the MazE/ MazF complex: molecular bases of antidote-toxin recognition. Mol. Cell 11:875- 884.
25. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. 2004. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186:8172- 8180.
26. Kolodkin-Gal I, Hazan R, Gaathon A, Carmeli S, Engelberg-Kulka H. 2007. A linear pentapeptide is a quorum-sensing factor required for mazEF-mediated cell death in Escherichia coli. Science 318:652- 655.
27. Korch SB, Hill TM. 2006. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J. Bacteriol. 188:3826 -3836.
28. Kuehne SA, et al. 2010. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711-713.
29. Li GY, et al. 2006. Characterization of dual substrate binding sites in the homodimeric structure of Escherichia coli mRNA interferase MazF. J. Mol. Biol. 357:139 -150.
30. Lyras D, et al. 2009. Toxin B is essential for virulence of Clostridium difficile. Nature 458:1176 -1179.
31. Makarova KS, Grishin NV, Koonin EV. 2006. The HicAB cassette, a putative novel, RNA-targeting toxin-antitoxin system in archaea and bacteria. Bioinformatics 22:2581-2584.
32. Moyed HS, Bertrand KP. 1983. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155:768 -775.
33. Nariya H, Inouye M. 2008. MazF, an mRNA interferase, mediates programmed cell death during multicellular Myxococcus development. Cell 132:55- 66.
34. Pandey DP, Gerdes K. 2005. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 33:966 -976.
35. Park JH, Yamaguchi Y, Inouye M. 2011. Bacillus subtilis MazF-bs (EndoA) is a UACAU-specific mRNA interferase. FEBS Lett. 585:2526 -2532.
36. Pellegrini O, Mathy N, Gogos A, Shapiro L, Condon C. 2005. The Bacillus subtilis ydcDE operon encodes an endoribonuclease of the MazF/ PemK family and its inhibitor. Mol. Microbiol. 56:1139 -1148.
37. Poutanen SM, Simor AE. 2004. Clostridium difficile-associated diarrhea in adults. CMAJ 171:51-58.
38. Privitera G, et al. 1991. Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery. Antimicrob. Agents Chemother. 35:208 -210.
39. Prysak MH, et al. 2009. Bacterial toxin YafQ is an endoribonuclease that associates with the ribosome and blocks translation elongation through sequence-specific and frame-dependent mRNA cleavage. Mol. Microbiol. 71:1071-1087.
40. Ramage HR, Connolly LE, Cox JS. 2009. Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet. 5:e1000767. doi:10.1371/journal.pgen.1000767.
41. Reynolds CB, Emerson JE, de la Riva L, Fagan RP, Fairweather NF. 2011. The Clostridium difficile cell wall protein CwpV is antigenically variable between strains, but exhibits conserved aggregationpromoting function. PLoS Pathog. 7:e1002024. doi:10.1371/ journal.ppat.1002024.
42. Riha WE, Jr, Solberg M. 1971. Chemically defined medium for the growth of Clostridium perfringens. Appl. Microbiol. 22:738 -739.
43. Rupnik M, Wilcox MH, Gerding DN. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 7:526 -536.
44. Sat B, et al. 2001. Programmed cell death in Escherichia coli: some antibiotics can trigger mazEF lethality. J. Bacteriol. 183:2041-2045.
45. Sat B, Reches M, Engelberg-Kulka H. 2003. The Escherichia coli mazEF suicide module mediates thymineless death. J. Bacteriol. 185:1803-1807.
46. Schmidt O, et al. 2007. prlF and yhaV encode a new toxin-antitoxin system in Escherichia coli. J. Mol. Biol. 372:894 -905.
47. Schwan C, et al. 2009. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog. 5:e1000626. doi:10.1371/journal.ppat.1000626.
48. Sebaihia M, et al. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779- 786.
49. van der Woude MW, Baumler AJ. 2004. Phase and antigenic variation in bacteria. Clin. Microbiol. Rev. 17:581- 611.
50. Vazquez-Laslop N, Lee H, Neyfakh AA. 2006. Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J. Bacteriol. 188:3494 -3497.
51. Yamaguchi Y, Park JH, Inouye M. 2009. MqsR, a crucial regulator for quorum sensing and biofilm formation, is a GCU-specific mRNA interferase in Escherichia coli. J. Biol. Chem. 284:28746 -28753.
52. Zhang Y, Zhang J, Hara H, Kato I, Inouye M. 2005. Insights into the mRNA cleavage mechanism by MazF, an mRNA interferase. J. Biol. Chem. 280:3143-3150.
53. Zhang Y, et al. 2003. MazF cleaves cellular mRNAs specifically at ACA to block protein synthesis in Escherichia coli. Mol. Cell 12:913-923.
54. Zhu L, et al. 2009. Staphylococcus aureus MazF specifically cleaves a pentad sequence, UACAU, which is unusually abundant in the mRNA for pathogenic adhesive factor SraP. J. Bacteriol. 191:3248 -3255.
55. Zhu L, et al. 2008. The mRNA interferases, MazF-mt3 and MazF-mt7 from Mycobacterium tuberculosis target unique pentad sequences in single-stranded RNA. Mol. Microbiol. 69:559 -569.
56. Zhu L, et al. 2006. Characterization of mRNA interferases from Mycobacterium tuberculosis. J. Biol. Chem. 281:18638 -18643.